GATC Health Featured on Citeline’s In Vivo Podcast: A “FICO Score” for Drug Development
June 17, 2026 — In the episode, titled “GATC Health’s Derisq AI, A FICO Score For Drug Development,” GATC Health Chief Business Officer Tyrone Lam explains how the Derisq ™ AI Report is revolutionizing the industry as a “FICO score” for drug development. You will learn how our Operon® platform’s highly accurate predictive modeling led a Lloyd’s of London syndicate to adopt the technology for underwriting clinical trial insurance. The discussion also dives into our recent PNAS-published collaboration with UC Irvine, detailing how Operon® was utilized to successfully validate GATC-1021, our novel candidate for opioid use disorder.
Listen to the full episode to here: GATC Health’s Derisq AI, A FICO Score For Drug Development
About GATC
GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. Trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners, GATC Health’s risk prediction product, the Derisq™ AI report, accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. GATC Health’s AI platform is also generative, creating novel intellectual property, extending pipelines, and optimizing assets. By uniting advanced AI, multiomics, and predictive modeling, GATC Health accelerates breakthroughs and reduces costly late-stage failures to bring safer, more effective therapies to patients worldwide. For more information, visit www.gatchealth.com.
Contact Us
Similar News
CTO Jayson Uffens Explains GATC Health’s AI Breakthrough
June 5, 2026 — In “Building a Biological Intelligence Layer for Drug Discovery,“ GATC Health CTO and co-founder, Jayson Uffens…
Read more
GATC Health Receives Concentrated Media Visibility Across AI, Capital Markets and Regulatory Policy Conversations
Recent coverage in BioSpace and GEN highlights GATC’s growing relevance in industry discussions spanning AI adoption, biotech financing, de…
Read more
GATC Health Strengthens Commercial and Pharma Strategy Leadership to Accelerate Market Adoption of Its AI Platform
IRVINE, CA — Feb. 26, 2026 — GATC Health, a leading tech-bio company leveraging AI to transform drug discovery and development, is pro…
Read more